SupplySide Connect - Food Science & Ingredients Supplier Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Shenyang Gold Jyouki Technology Co., Ltd.

Liaoning 110211

Company Profile

Shenyang Gold Jyouki Technology Co., Ltd. established in 2005, is

a modern chemical enterprises promoted by technology. The company

has first-class production equipment, strict quality management system,

high-quality standard R & D environment and series of products with the

world's advanced level.

The company's dual-function bimetallic chiral series of catalyst

production and application technology own independent intellectual

property rights. With strong R & D strength and innovative technology,

Jyouki realized scaled and serialized production for the chiral alkylene

oxide and chiral diol compounds. With 15 years of innovation and

accumulation, the company continues to introduce a series of high-quality

chiral compounds, involves in new drug R&D of international

pharmaceutical enterprises and further promotes the strategic cooperation

with the pharmaceutical production enterprises. The company acquired

Fushun Grandakem Co., Ltd. in November 2015 with a register capital of

RMB 39.08 million. Jyouki Pharmaceutical Co., Ltd. is a wholly-owned

subsidiary of Shenyang Gold Jyouki Technology Co., Ltd. , and

implemented the expansion of production, the company's existing

construction area of over 14,000m2, more than 300 sets of equipment,

planning to construct four workshops. The company is located in Fushun

High-tech Industrial Development Zone, occupies an area of

approximately 60 acres and currently has 130 employees. The company

has completed the construction of three workshops and equipment

installation, including chiral pharmaceutical intermediates production

workshop, multi-functional pilot plant and a cGMP workshop. Build an

annual output of 6,000 tons of chiral epoxy series of pharmaceutical

intermediates production line to meet the rapid growth of market demand.

With advanced technology as the support, first-class production

equipment and perfect quality management system, the products have

always maintained high quality competitive advantages in the same

industry across the country, and have been exported to many parts of the

world , such as, India, South Korea, Japan, The United States, Europe and

other countries and areas.


  • L-A-glycerophosphorylcholine
  • choline alfoscerate
  • S-Epichlorohydrin
  • 3-chloro-1,2-propanediol
  • R-Glycidyl butyrate
  • R-Propylene carbonate
  • Ethyl R-3-hydroxybutyrate